Compositions and methods for inhibiting the activity of LAR family phosphatases
US9937242B2 · kind B2 · utility
5Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2013 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | May 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/03048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting and/or reducing the activity, signaling, and/or function of leukocyte-common antigen related (LAR) family of phosphatases in a cell of a subject induced by proteoglycans includes administering to the cell a therapeutic agent that inhibits one or more of catalytic activity, signaling, and function of the LAR family phosphatases without inhibiting binding to or activation the LAR family phosphatases by the proteoglycans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.